Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPAS: Synflorix Efficacy Against Pneumonia and Otitis Media
NCT00466947Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Primary completion
- Aug 2010
- Modality
- Split/Subunit Vaccines
- Countries
- 3
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in community acquired pneumonia (CAP), acute otitis media (AOM), sponsored by GSK. Started Jun 2007; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
community acquired pneumonia (CAP)acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00466947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466947.